MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

International Operation Combats Online Supply of Counterfeit and Illegal Medicines

20th November 2009 LYON, France, November 20 /PRNewswire/ -- In response to an ever-increasing number of websites supplying dangerous and illegal medicines, Operation Pangea II, involving 24 countries, was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight the dangers of buying medicines online. The week long global initiative resulted in a series of arrests and the seizure of thousands of potentially harmful medical... more

Apieron Alleges Evidence Shows Aerocrine Inventors Withheld Prior Art Information from Patent Office

18th November 2009 MENLO PARK, California, November 18 /PRNewswire/ -- Apieron, Inc. has asked the court presiding over its patent suit against Aerocrine, Inc. to allow it to raise additional grounds for invalidating Aerocrine's broadest patent relating to exhaled nitric oxide, U.S. Patent No. 5,922,610. In its motion, Apieron alleges that recently obtained deposition testimony and interrogatory responses indicate that Drs. Kjell Alving, Jan Lundberg, and Edward Weitzberg, inventors named on the '610 patent,... more

Internet Sales of Dermocosmetics: the Paris Court of Appeal Refers the Case to the Court of Justice of the European Communities

6th November 2009 CASTRES, France, November 6 /PRNewswire/ -- The case opposing the French Competition Authority and Pierre Fabre Dermocosmetics (PFDC) came before the Paris Court of Appeal on Thursday, 29 October 2009. It may be remembered that in this case, the "Conseil de la Concurrence" (now called Autorité de la Concurrence) [Competition Council , now called the Competition Authority] condemned Pierre Fabre Dermocosmetics to pay a fine of EUR17,000 and ordered the company to allow its products to be... more
Legal Issues RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process
22nd October 2009 WELLESLEY HILLS, Massachusetts, October 22 /PRNewswire/ -- The previously announced auction of assets of EPIX Pharmaceuticals, Inc. was conducted on October 21, 2009. As of today, claims filed...

EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
16th October 2009 WELLESLEY HILLS, Massachusetts, October 16 /PRNewswire/ -- The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4...

Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
13th October 2009 PHILADELPHIA, October 13 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc....

Occlutech Receives Positive Ruling in German Proceeding Initiated by AGA Medical
23rd September 2009 JENA, Germany, September 23 /PRNewswire/ -- Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an...

Drink-Drive Cambridgeshire Vet Warned as to Future Conduct
21st September 2009 LONDON, September 21 /PRNewswire/ -- Following a two-year postponed judgment, the Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week [17 September 2009] warned a...

Welsh Health Minister's Ban on Advertising in Hospitals Will Cost the NHS GBP1 Million
18th September 2009 LONDON, September 18 /PRNewswire/ -- Health Minister Edwina Hart's directive to ban all legal service advertising in hospitals could cost the Welsh NHS trusts GBP1 million in compensation through...

EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction
1st September 2009 WELLESLEY HILLS, Massachusetts, September 1 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that the P2Y2 Gastrointestinal Early Development Candidate Program will be part of...

Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
18th August 2009 WELLESLEY HILLS, Massachusetts, August 18 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that the PRX-08066 Therapeutics Program in Phase 2 for respiratory indication will be...

Class Action Notice for Minnesota Light Cigarette Litigation From Lommen, Abdo, Cole, King & Stageberg, P.A.
4th August 2009 MINNEAPOLIS, August 4 /PRNewswire/ -- Court ordered Class Notice in Curtis, et al., v Altria Group, Inc. and Philip Morris USA, Inc., et al., court File No. 27-CV-01-18042 (action filed 11/28/01). ...

Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
30th July 2009 TAINAN, Taiwan, July 30 /PRNewswire/ -- Eli Lilly & Company ("Lilly") and ScinoPharm Taiwan Ltd. ("ScinoPharm") announced today that they have reached an amicable resolution of all ongoing patent...

Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat
23rd July 2009 MUMBAI, July 23 /PRNewswire/ -- After receiving approval from the Drug Controller General of India(DCGI) for a multi-centre Phase IIb clinical study for its lead COPD/asthma molecule, Oglemilast,...

UK Court of Appeal Rules in Smith & Nephew's Favour
14th July 2009 HULL, England, July 14 /PRNewswire/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN) (NYSE: SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted...

Trimega Laboratories: Drunk Parents Risk Losing Children in Hair Tests
8th July 2009 LONDON, July 8 /PRNewswire/ -- Divorcing parents who embark on a hedonistic lifestyle are in danger of losing custody of their children thanks to a growing trend in hair test requests to gauge how...

The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica
9th May 2009 KVISTGARD, Denmark, May 9 /PRNewswire/ -- Oxford Biomedica's second attempt to dismiss Bavarian Nordic's patent infringement suit in the United States has failed. Instead of denying infringement,...

Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
7th May 2009 PHILADELPHIA, Pennysylvania, May 7 /PRNewswire/ -- Elsevier, one of the world's leading publishers of scientific, technical, and medical (STM) information products and services, announced today...

Call for Northern Ireland Abortion Guidelines to be Withdrawn
22nd April 2009 BELFAST, Northern Ireland, April 22 /PRNewswire/ -- Pro-life campaigners are calling on Mr Michael McGimpsey MLA, Northern Ireland's health minister, to withdraw the controversial guidelines...

Gunther Von Hagens' BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
22nd April 2009 HEIDELBERG, Germany, April 22 /PRNewswire/ -- The Institute for Plastination in Heidelberg, Germany and its Scientific Director, anatomist Dr. Gunther von Hagens - creators of the world...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us